Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer

Clinical trial NCT00654238 · COMPLETED

Trial details

NCT number: NCT00654238
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Differentiated Thyroid Cancer Metastatic Poorly Differentiated Thyroid Cancer Metastatic Anaplastic Thyroid Cancer Metastatic Medullary Thyroid Cancer

Start date: 2006-02-01
Primary completion: 2010-12-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.